Due to the possible emergence of resistance and safety concerns on certain treatments, development of new drugs against parasites is essential for the effective control and subsequent eradication of parasitic infections. Several drug targets have been identified which are either genes or proteins essential for the parasite survival and distinct from the hosts. These include the phosphagen kinases (PKs) which are enzymes that play a key role in maintenance of homeostasis in cells exhibiting high or variable rates of energy turnover by catalizing the reversible transfer of a phosphate between ATP and naturally occurring guanidine compounds. PKs have been identified in a number of important human and animal parasites and were also shown to be significant in survival and adaptation to stress conditions. The potential of parasite PKs as novel chemotherapeutic targets remains to be explored.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018575 | PMC |
| http://dx.doi.org/10.3347/kjp.2010.48.4.281 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A review of acaricides and their resistance mechanisms in hard ticks and control alternatives with synergistic agents.
Acta Trop
December 2024
Centro de Investigación en Alimentación y Desarrollo, A. C. (CIAD), 83304 Hermosillo, Sonora, Mexico. Electronic address:
Article Synopsis
- Ticks are major ectoparasites that spread serious diseases like Lyme disease and Rocky Mountain spotted fever, posing challenges for public health and livestock due to emerging resistance to acaricides.
- The review discusses how genetic mutations, metabolic processes, and behavior contribute to this resistance, while also highlighting the economic impact estimated at $20 billion in livestock loss annually.
- It emphasizes the need for new acaricides, innovative control strategies, and regular monitoring to effectively manage tick populations and protect public health and livestock productivity.
A Crystal Structure of Pro c 2 Provides Insights into Cross-Reactivity of Aquatic Allergens from the Phosphagen Kinase Family.
J Agric Food Chem
December 2024
College of Ocean Food and Biological Engineering, Jimei University, Xiamen, Fujian 361021, China.
Arginine kinase (AK) from the phosphagen kinase family is a cross-reactive shellfish allergen. Structurally related cross-reactive allergens are involved in the pathogenesis of allergic symptoms. This study aimed to unravel the cross-reactivity of AK from a structural perspective.
View Article and Find Full Text PDFMaintaining energy provision in the heart: the creatine kinase system in ischaemia-reperfusion injury and chronic heart failure.
Clin Sci (Lond)
April 2024
Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, United Kingdom.
The non-stop provision of chemical energy is of critical importance to normal cardiac function, requiring the rapid turnover of ATP to power both relaxation and contraction. Central to this is the creatine kinase (CK) phosphagen system, which buffers local ATP levels to optimise the energy available from ATP hydrolysis, to stimulate energy production via the mitochondria and to smooth out mismatches between energy supply and demand. In this review, we discuss the changes that occur in high-energy phosphate metabolism (i.
View Article and Find Full Text PDFMitochondrial phosphagen kinases support the volatile power demands of motor nerve terminals.
J Physiol
December 2023
Wilkes Honors College, Florida Atlantic University, Jupiter, FL, USA.
Motor neurons are the longest neurons in the body, with axon terminals separated from the soma by as much as a meter. These terminals are largely autonomous with regard to their bioenergetic metabolism and must burn energy at a high rate to sustain muscle contraction. Here, through computer simulation and drawing on previously published empirical data, we determined that motor neuron terminals in Drosophila larvae experience highly volatile power demands.
View Article and Find Full Text PDFAspects of human uterine creatine metabolism during the menstrual cycle and at term pregnancy†.
Biol Reprod
December 2023
The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia.
Article Synopsis
- The study investigates the role of creatine metabolism in the human uterus, focusing on whether the uterus can synthesize creatine and how this metabolism changes during the menstrual cycle and pregnancy.
- Researchers examined the expression of key creatine-synthesizing enzymes and transporters in the endometrial tissue of both fertile and primary infertile women, finding that certain proteins were most active during the early secretory phase of the menstrual cycle.
- The results show that the pregnant uterus contains all necessary components for creatine metabolism, indicating that endometrial tissue has the capacity to produce creatine, especially around fertilization and implantation.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!